AI Article Synopsis

  • * Immunohistochemistry tests often fail to determine the primary cancer origin in about one-third of cases, which can hinder treatment decisions.
  • * In a specific case, a 54-year-old man with undiagnosed lower back pain was correctly diagnosed with male breast cancer through microRNA testing after other methods failed.

Article Abstract

Cancers of unknown primary (CUP) constitute a significant diagnostic and therapeutic challenge for clinicians and a frequent cause of cancer-related mortality in Western countries. Immunohistochemistry assays are commonly used to identify the primary cancer, but fail in approximately one-third of cases. The identification of the possible origin of CUP is crucial, as it may help select the appropriate treatment options. We herein present the case of a 54-year-old male patient, who presented with lower back pain in June, 2013. Following a thorough investigation, the clinical and pathological findings could not identify the primary cancer, leading towards a misdiagnosis. Ultimately, microRNA testing of the resected spine lesion was able to identify the primary tumor as male breast cancer and allow for optimal treatment of the patient.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950128PMC
http://dx.doi.org/10.3892/mco.2016.912DOI Listing

Publication Analysis

Top Keywords

identify primary
12
unknown primary
8
male breast
8
breast cancer
8
primary cancer
8
cancer
5
primary
5
cancer unknown
4
primary ultimately
4
ultimately diagnosed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!